Regeneron Pharmaceuticals Inc. buy Erntehelfer
Start price
06.08.21
/
50%
€508.90
Target price
06.08.22
-
Performance (%)
17.82%
End price
06.08.22
€599.60
Summary
This prediction ended on 06.08.22 with a price of €599.60. The BUY prediction by Erntehelfer finished with a performance of 17.82%. Erntehelfer has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Regeneron Pharmaceuticals Inc. | 3.683% | 3.683% | -0.311% | -5.812% |
| iShares Core DAX® | -0.121% | 2.507% | 16.129% | 61.530% |
| iShares Nasdaq 100 | 0.081% | -0.241% | 4.636% | 97.770% |
| iShares Nikkei 225® | -1.748% | 4.105% | 16.103% | 48.713% |
| iShares S&P 500 | -0.961% | -0.143% | 1.644% | 62.430% |
Comments by Erntehelfer for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren
Erntehelfer hat das Wertpapier Regeneron Pharmaceuticals Inc. in seinem Wikifolio Doppelanalyse (Chance) SL+ gekauft.
In the thread Trading Regeneron Pharmaceuticals Inc.
Die von Erntehelfer gewählte maximale Laufzeit wurde überschritten